Table 3.

Patient details.

ID	Stage	MMR	PDL1	Prior lines	# Cycles	iRECIST	PFS (m)	OS (m)
1	IV	MMRp	PDL1-	2	4	Progression	3.3	Dead of disease at 9.9 months
2	III	MMRp	PDL1-	2	2	Progression	0.9	Dead of disease at 2.8 months
3	IV	MMRd	PDL1+	2	2	Progression	1.6	Dead of disease at 2.4 months
4	III	MMRp	PDL1-	2	4	Progression	2.6	Dead of disease at 2.8 months
5	III	MMRp	PDL1-	4	3	Progression	1.9	Dead of disease at 2.1 months
6	III	MMRp	PDL1-	3	6	Stable	–	Alive with disease at 4.4 months
7	I	MMRp	PDL1-	2	16	Stable then progression	11.2	Alive with disease at 12.6 months

MMRp, mismatch repair proficient; MMRd, mismatch repair deficient; PFS, progression-free survival; OS, overall survival.